Business
RAC) share price jumps 13% on study breakthrough
Image source: Getty Images
Shares in Australian pharmaceutical company Race Oncology Ltd (ASX: RAC) jumped higher today and finished 13% in the green.
Investors bid up the Race Oncology share price following study readouts for its lead drug candidate, Zantrene, in a heart safety research…
Continue Reading
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News23 hours agoNicole Kidman Is Back in Wellness Guru Mode: ‘Nine Perfect Strangers’ Season Two Will Hit Your Streaming Queue in May
-
Noosa News20 hours agoCloud Control celebrate 15 years of debut album Bliss Release with reunion tour
-
General17 hours agoUK’s AUKUS inquiry is unlikely to suggest the government pull out, expert says